Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDimmatics biotechnologies GmbH Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 0 | $0.00 | $0.00 | $0.00 |
immatics biotechnologies GmbH Earnings Date And Information
immatics biotechnologies GmbH last posted its earnings results on N/A. The company reported $N/A earnings per share for the quarter, missing analysts' consensus estimates of $N/A by $0. The company had revenue of 50.56 M for the quarter and had revenue of 54.00 M for the year. immatics biotechnologies GmbH has generated $-1 earnings per share over the last year ($-1.2 diluted earnings per share) and currently has a price-to-earnings ratio of -10.03. immatics biotechnologies GmbH has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, June 8th, 2020 based on prior year's report dates.
immatics biotechnologies GmbH Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/18/2024 | Q3 2024 | $0.00 | $15.91 M | $50.56 M | ||
| 08/13/2024 | Q2 2024 | -$0.17 | $18.76 M | |||
| 05/14/2024 | Q1 2024 | -$0.03 | $30.45 M | |||
| 03/21/2024 | Q4 2023 | -$0.31 | $15.92 M | |||
| 09/29/2023 | Q3 2023 | -$0.32 | $5.93 M | |||
| 05/16/2023 | Q2 2023 | -$0.32 | $22.35 M | |||
| 05/16/2023 | Q1 2023 | -$0.20 | $9.80 M | |||
| 03/22/2023 | Q4 2022 | -$0.19 | $37.65 M | |||
| 11/17/2022 | Q3 2022 | -$0.32 | $15.06 M | |||
| 06/02/2022 | Q2 2022 | -$0.22 | $17.22 M | |||
| 06/02/2022 | Q1 2022 | $1.36 | $102.91 M | |||
| 11/16/2021 | Q4 2021 | -$0.27 | $15.73 M | |||
| 08/10/2021 | Q3 2021 | -$0.43 | $6.44 M | |||
| 05/18/2021 | Q2 2021 | -$0.38 | $5.19 M | |||
| 05/18/2021 | Q1 2021 | -$0.34 | $7.40 M | |||
| 12/02/2020 | Q4 2020 | -$0.36 | $9.45 M | |||
| 07/08/2020 | Q3 2020 | -$2.82 | $7.87 M | |||
| 07/08/2020 | Q2 2020 | -$0.33 | $6.90 M | |||
| 03/30/2020 | Q1 2020 | -$0.13 | $7.04 M | |||
| 12/30/2019 | Q4 2019 | -$0.23 | $4.38 M |
immatics biotechnologies GmbH Earnings: FAQ's
When is immatics biotechnologies GmbH's earnings date?
immatics biotechnologies GmbH has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, June 8th, 2020 based off last year's report dates.
How can I listen to immatics biotechnologies GmbH's earnings conference
call?
The conference call for immatics biotechnologies GmbH's latest earnings report can be listened to online.
How can I read immatics biotechnologies GmbH's conference call transcript?
The conference call transcript for immatics biotechnologies GmbH's latest earnings report can be read online.
How much revenue does immatics biotechnologies GmbH generate each year?
immatics biotechnologies GmbH (:IMTXW) has a recorded annual revenue of $54.00 M.
How much profit does immatics biotechnologies GmbH generate each year?
immatics biotechnologies GmbH (:IMTXW) has a recorded net income of $54.00 M. immatics biotechnologies GmbH has generated $-1.2 earnings per share over the last four quarters.
What is immatics biotechnologies GmbH's price-to-earnings ratio?
immatics biotechnologies GmbH (:IMTXW) has a price-to-earnings ratio of -10.03 and price/earnings-to-growth ratio is -0.26.